FDA NDA · NDA022000

LIALDA

mesalamine

Sponsor: TAKEDA PHARMS USA

What this page does not claim

A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.

APPLICATION
NDA022000
TYPE
NDA
ORIGINAL APPROVAL
2007-01-16
LATEST ACTION
2026-10-14
ROUTE
ORAL
DOSAGE FORM
TABLET, DELAYED RELEASE
MARKETING STATUS
Prescription

Products

LIALDA · ReferencePrescription
MESALAMINE 1.2GM · TABLET, DELAYED RELEASE · ORAL

Approval history

2026-10-14Labeling · Supplement 30 · standard — Letter ↗AP
2023-10-24Labeling · Supplement 27 · standard — Label ↗AP
2022-11-16Labeling · Supplement 25 · standard — Letter ↗AP
2021-11-01Labeling · Supplement 23 · standard — Letter ↗AP
2021-05-25Labeling · Supplement 22 · standard — Letter ↗AP
2020-12-17Labeling · Supplement 21 · standard — Label ↗AP
2020-10-01Labeling · Supplement 20 · standard — Letter ↗AP
2020-06-26Efficacy · Supplement 19 · standard — Letter ↗AP
2019-07-18Labeling · Supplement 18 · standard — Label ↗AP
2018-05-23Labeling · Supplement 17 · standard — Letter ↗AP
2017-08-22Labeling · Supplement 15 · standard — Label ↗AP
2017-07-27Labeling · Supplement 16 · standard — Letter ↗AP
2014-10-16Labeling · Supplement 13 · standard — Label ↗AP
2014-03-14Labeling · Supplement 12 · standardAP
2013-12-16Labeling · Supplement 11 · standard — Label ↗AP
2013-08-28Labeling · Supplement 9 · standard — Letter ↗AP
2013-08-09Labeling · Supplement 10 · standard — Letter ↗AP
2013-08-09Labeling · Supplement 8 · standard — Label ↗AP
2011-07-14Efficacy · Supplement 5 · standard — Label ↗AP
2010-09-22Labeling · Supplement 3 · standard — Label ↗AP
2009-10-30Labeling · Supplement 2 · standard — Label ↗AP
2007-01-16Type 3 - New Dosage Form · Original · standard — Review ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →